Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Studies add new findings to cervical cancer body of knowledge
October 20th, 2005
New findings from India, Hungary and Brazil describe advances in cervical cancer. Study 1: Molecular immunology borstel (MIB)-1 and proliferating cell nuclear antigen (PCNA) immunostaining were used as diagnostic tools for cervical cancer. According to recent research from India, "The present study was done to determine the role of MIB-1 and PCNA proliferative index as a diagnostic adjunct to cervical Papanicolaou (Pap) smear for the identification of ascending grades of cervical intraepithelial neoplasia (CIN) developing into cancer in the human uterine cervix. A total of 49 adequate Pap smears with consensus diagnosis were destained for...
Source: Women's Health Weekly (2005-10-20)
|
